Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/26/2010 | CN101129748B Proprietary Chinese medicine for treating cancer of the lungs and method of preparing the same |
05/26/2010 | CN101125159B Medicine for treating hemorrhoid, anal fissure and anal fistula |
05/26/2010 | CN101120977B Medicine for treating tumor |
05/26/2010 | CN101099814B Medicinal composition for delaying male senility |
05/26/2010 | CN101099762B Blood pressue lowering sustained-release preparation with chrysanthemum flower and pearl |
05/26/2010 | CN101095688B Application of mannose in the preparation of medicine for treating pulmonary inflammation disease |
05/26/2010 | CN101066258B Inclusion compound of higher fatty alcohol and its preparation |
05/26/2010 | CN101062377B Adhesive plaster for diminishing inflammation, expelling wind and cold |
05/26/2010 | CN101062260B Granule for complementing Yin and preventing anxiety and its production method |
05/26/2010 | CN101062233B Powdered medicine for coaptation and its preparing process |
05/26/2010 | CN101062210B Chinese medicine for treating bone disease |
05/26/2010 | CN101045134B Method for preparing medicine to treat atherosclerosis |
05/26/2010 | CN101045051B Novel use of tizanidine or its derivatives in preparing medicine for prolonging fast wave sleep |
05/26/2010 | CN101040847B Nanometer medicine agent produced by hydrogenated castor oil and the technique of preparing the same |
05/26/2010 | CN101032531B Hyperfine Chinese traditional medicine pieces taken with or without water and the preparing method |
05/26/2010 | CN101032484B Capsule type tiotropium bromide inhalation powder |
05/26/2010 | CN101028281B Nano-gel pectin bismuth and its granules medicine |
05/26/2010 | CN101020027B Medicine composition for preventing and treating AIDS and its preparation process and use |
05/26/2010 | CN101019836B Nanometer cytochrome liposome medicine and its preparation |
05/26/2010 | CN101015648B Use of succinic acid derivative eater compound for treating dementia |
05/25/2010 | US7725329 System and method for automatic generation of a hierarchical tree network and the use of two complementary learning algorithms, optimized for each leaf of the hierarchical tree network |
05/25/2010 | US7725026 Phase responsive optical fiber sensor |
05/25/2010 | US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines |
05/25/2010 | US7723467 Antimicrobial compounds |
05/25/2010 | US7723390 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism |
05/25/2010 | US7723379 Dosage form of polysaccharides, especially cocoa extracts, containing procyanidine units an additional nitric oxide modulating agent; dietary supplements; pet foods |
05/25/2010 | US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor |
05/25/2010 | US7723344 Dipeptidyl peptidase inhibitors |
05/25/2010 | US7723320 Use of estrogen compounds to increase libido in women |
05/25/2010 | US7723311 Delivery of bioactive substances to target cells |
05/25/2010 | US7723310 increasing patient compliance in treatment of hepatitis-C virus infection |
05/25/2010 | US7723306 such as glucosyl and maltosyl sucrose; storage stability |
05/25/2010 | US7723304 Hypotensive agents; cardiovascular disorders; wound healing agents; antitumor agents; antidiabetic agents ; nephropathy; gastrointestinal disorders; alopecia; blood disorders ; urogenital disorders |
05/25/2010 | US7723091 combination of a mannanase and a carrier that is adapted for oral administration and does not contain an anti-infection agent other than the mannanase; treating or ameliorating the risk of a digestive tract infection, particularly of Eimeria, Cryptosporidium, or Clostridium |
05/25/2010 | US7723087 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
05/25/2010 | US7723056 Particles |
05/25/2010 | US7723035 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells |
05/25/2010 | US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders |
05/25/2010 | US7722899 Surface-treated powder and cosmetic preparation |
05/25/2010 | US7722898 Modified-release preparations containing oxcarbazepine and derivatives thereof |
05/25/2010 | US7722896 Biocompatible polyarylates of diphenol compounds and poly(alkylene oxide) dicarboxylic acids, articles formed therefrom and therapeutic uses are disclosed. |
05/25/2010 | US7722891 Multiple emulsions |
05/25/2010 | US7722696 Coated granular substances |
05/25/2010 | US7722598 Apparatus and system for delivery of drug therapies |
05/25/2010 | CA2582666C Controlled release implant |
05/25/2010 | CA2577589C Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation |
05/25/2010 | CA2441352C Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
05/25/2010 | CA2440763C Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles |
05/25/2010 | CA2434961C L-histidine in ophthalmic solutions |
05/25/2010 | CA2426263C Nateglinide-containing preparation |
05/25/2010 | CA2420523C Controlled and sustained release properties of polyelectrolyte multilayer capsules |
05/25/2010 | CA2419825C Hard capsule made from a polymer or copolymer formed by polymerizing at least one polymerizable vinyl monomer in the presence of polyvinylalcohol or a derivative thereof |
05/25/2010 | CA2407079C Fluid material dispensing syringe |
05/25/2010 | CA2400444C Medical adhesive composition, medical adhesive tape using the same and tape preparation for percutaneous absorption |
05/25/2010 | CA2394471C External preparation for treating pruritus |
05/25/2010 | CA2375923C Devices and compounds for treating arterial restenosis |
05/25/2010 | CA2375727C Cytofectin dimers and methods of use thereof |
05/25/2010 | CA2368621C Methods and compositions for treating solid tumors |
05/25/2010 | CA2361573C Biodegradable glass compositions and methods for radiation therapy |
05/25/2010 | CA2342121C Powdered mannitol and the procedure for preparing it |
05/25/2010 | CA2330237C Broad specificity dna damage endonuclease |
05/25/2010 | CA2310147C Spheroids, preparation method and pharmaceutical compositions |
05/25/2010 | CA2290805C Powdered sorbitol and its preparation |
05/25/2010 | CA2199715C Novel implant and novel vector for the treatment of acquired diseases |
05/20/2010 | WO2010057215A1 Engineering porous particles of water soluble therapeutics for pressurized metered-dose inhaler formulations |
05/20/2010 | WO2010057214A2 Nanoparticles and porous particles and methods of making the same |
05/20/2010 | WO2010057189A1 Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
05/20/2010 | WO2010057188A2 Fast-acting, dietary supplement containing compositions and methods of producing the compositions |
05/20/2010 | WO2010057160A1 Releasable fusogenic lipids for nucleic acids delivery systems |
05/20/2010 | WO2010057140A1 Dental appliance cleanser |
05/20/2010 | WO2010057117A2 Topical transdermal drug delivery compositions |
05/20/2010 | WO2010057036A2 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof |
05/20/2010 | WO2010057034A1 Compositions and methods for alleviating hyposalivation and for providing oral comfort |
05/20/2010 | WO2010057007A1 Organogel compositions and processes for producing |
05/20/2010 | WO2010056957A1 Controlled release food formulations |
05/20/2010 | WO2010056847A2 Lyophilization formulation |
05/20/2010 | WO2010056754A2 Inhibition of mammalian target of rapamycin |
05/20/2010 | WO2010056598A2 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof |
05/20/2010 | WO2010056216A1 Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine |
05/20/2010 | WO2010056065A2 Method for preparing microspheres and microspheres produced thereby |
05/20/2010 | WO2010056039A2 Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability |
05/20/2010 | WO2010055974A1 Composition for preventing and treating diabetes and metabolic syndrome disorders containing obovatol and derivatives thereof as active ingredients |
05/20/2010 | WO2010055963A1 Manufacturing method of acetate-free dialysate composition |
05/20/2010 | WO2010055950A1 Novel cancer targeting therapy using complex of substance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound |
05/20/2010 | WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide |
05/20/2010 | WO2010055622A1 Simple device for treating trichophytosis unguium |
05/20/2010 | WO2010055416A1 Dispersion and debundling of carbon nanotubes using gemini surfactant compounds |
05/20/2010 | WO2010055304A2 Pharmaceutical compounds |
05/20/2010 | WO2010055268A1 Novel method for preparing granulates of active principles, and granulates obtained thereof |
05/20/2010 | WO2010055260A1 Novel composition based on gamma-hydroxybutyric acid |
05/20/2010 | WO2010055252A2 Plant-based granules |
05/20/2010 | WO2010055119A2 Pharmaceutical composition comprising pimobendan |
05/20/2010 | WO2010054845A1 Improved dissolution stability of calcium carbonate tablets |
05/20/2010 | WO2010054833A1 Intermediate and oral administrative formats containing lenalidomide |
05/20/2010 | WO2010054654A1 Modified cationic liposome adjuvans |
05/20/2010 | WO2010054533A1 Cyproheptadine hydrochloride cream and preparation method thereof |
05/20/2010 | WO2010054507A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives |
05/20/2010 | WO2010054495A2 Non-aqueous colloidal formulation |
05/20/2010 | WO2010054446A1 Combination of two or more peptides in a single stable lyophilized pharmaceutical compound |
05/20/2010 | WO2010035268A3 Device for photodynamical therapy of cancer |